UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests in Operating Subsidiaries
Beginning balance (in shares) at Dec. 31, 2024		96,048,999
Beginning balance at Dec. 31, 2024	$ 552,619	$ 96	$ (118,542)	$ 910,237	$ (275,786)	$ (1,180)	$ 37,794
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) including noncontrolling interests in subsidiaries	23,528				24,287		(759)
Other comprehensive income	662					662
Issuance of common stock for vesting of restricted stock units (in shares)		244,629
Shares withheld related to net share settlement of share-based awards (in shares)		(121,926)
Shares withheld related to net share settlement of share-based awards	(471)			(471)
Compensation expense for share-based awards	922			922
Ending balance (in shares) at Mar. 31, 2025		96,171,702
Ending balance at Mar. 31, 2025	577,260	$ 96	(118,542)	910,688	(251,499)	(518)	37,035
Beginning balance (in shares) at Dec. 31, 2025		96,475,469
Beginning balance at Dec. 31, 2025	584,032	$ 96	(118,542)	915,330	(254,104)	670	40,582
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) including noncontrolling interests in subsidiaries	(17,601)				(15,741)		(1,860)
Other comprehensive income	114					114
Issuance of common stock for vesting of restricted stock units (in shares)		171,296
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)		10,395
Shares withheld related to net share settlement of share-based awards (in shares)		(68,028)
Shares withheld related to net share settlement of share-based awards	(320)			(320)
Compensation expense for share-based awards	1,000			1,000
Ending balance (in shares) at Mar. 31, 2026		96,589,132
Ending balance at Mar. 31, 2026	$ 567,225	$ 96	$ (118,542)	$ 916,010	$ (269,845)	$ 784	$ 38,722